4 transcripts
EYE
Earnings call transcript
NASDAQ
2024 Q2
7 Aug 24
. So the overall assessment that we're looking to evaluate with the store optimization is less than 5% of our total store fleet, and that's across all
EYE
Earnings call transcript
NASDAQ
2024 Q1
8 May 24
was also granted its second breakthrough designation by the FDA. This time for its chronic kidney disease assessment AI which follows the designation
EYE
Earnings call transcript
NASDAQ
2023 Q4
27 Feb 24
capabilities beyond the planned 600 stores by the end of 2024, we want to ensure we are taking a measured approach as we assess new states and markets
EYE
Earnings call transcript
NASDAQ
2023 Q2
10 Aug 23
that are significantly lower than company average. Is that a fair assessment?
Yes, for sure. And especially those dark sales, they are quite a quite a drag
- Prev
- 1
- Next